Lisi S.A.
FII
Rang in aandelen
#4645
Lisi S.A. is a global provider of specialized assembly and component solutions,... Lisi S.A. is a global provider of specialized assembly and component solutions, primarily serving the aerospace, automotive, and medical sectors. The company organizes its operations into three distinct divisions: LISI Aerospace, LISI Automotive, and LISI Medical. LISI Aerospace specializes in advanced aircraft components, including titanium fasteners, lightning protection, safety locking mechanisms, and fuse pins. Their contributions to the LEAP engine encompass compressor blades, struts, and composite fan blade leading edges. They also produce air intake lipskins for Airbus aircraft, semi-machined gears for power transmission, stator vanes, and satellite antenna mounting brackets for both airplanes and helicopters. LISI Automotive delivers a broad spectrum of fastening and component solutions for vehicles. This includes guide pins, electric parking brake elements, complete braking systems, and direct engine injection parts. They supply various fasteners like screws, nuts, and specialized clips for interior and exterior trim, alongside components for seat belt mechanisms, motor systems, and safety applications. The division also focuses on assembly optimization, offering cable ducts, battery fastening systems, intricate power transmission parts, and standard automotive fasteners. Furthermore, they provide clipped fastening solutions for both internal and external cladding, specialized fasteners for tubes and cables, and products designed to reduce weight and streamline assembly processes. Their portfolio extends to critical components for braking, fluid management, seat adjustment, and interior safety systems. LISI Medical is involved in the complete lifecycle of medical device development, from initial design and modeling through prototyping, pre-series production, material selection, process validation, and inventory management. They manufacture a range of orthopedic reconstruction implants for shoulders, hips, knees, and extremities, along with associated surgical instruments. The division also produces various surgical tools, such as blades, scissors, staplers, and pliers. Additionally, they provide spinal and trauma implants, including connectors, screws, cages, plates, and prostheses, specifically designed for treating trauma and facilitating osteosynthesis. Established in 1777, the company, originally known as GFI Industries, adopted the name LISI S.A. in 2002. Headquartered in Belfort, France, it operates as a subsidiary of Compagnie Industrielle De Delle S.A.
Aandeelprijs
$68.50
Marktkapitalisatie
$3.13B
Verandering (1 dag)
-5.63%
Verandering (1 jaar)
24.20%
Land
FR
Handel Lisi S.A. (FII)
Categorie
Industrials
P/E-ratio voor Lisi S.A. (FII)
P/E-ratio op October 2026 TTM: 16.79
Volgens de meest recente financiële rapporten en aandelenkoers van Lisi S.A. is de huidige P/E-ratio (TTM) 16.79. Eind 2023 had het bedrijf een P/E van 28.43.
Historiek van P/E-ratio voor Lisi S.A. van 2002 tot 2026
P/E-ratio aan het einde van elk jaar
| Jaar | P/E-verhouding | Wijzigen |
|---|---|---|
| 2026 (TTM) | 16.79 | -6.16% |
| 2024 | 17.89 | -37.10% |
| 2023 | 28.43 | 57.26% |
| 2022 | 18.08 | -46.95% |
| 2021 | 34.08 | -219.26% |
| 2020 | -28.58 | -224.66% |
| 2019 | 22.93 | 93.55% |
| 2018 | 11.85 | -39.58% |
| 2017 | 19.60 | 29.37% |
| 2016 | 15.15 | -5.93% |
| 2015 | 16.11 | 16.08% |
| 2014 | 13.88 | -8.34% |
| 2013 | 15.14 | 34.24% |
| 2012 | 11.28 | 26.61% |
| 2011 | 8.91 | -43.55% |
| 2010 | 15.78 | -57.82% |
| 2009 | 37.41 | 725.16% |
| 2008 | 4.53 | -54.00% |
| 2007 | 9.86 | -26.80% |
| 2006 | 13.46 | -2.43% |
| 2005 | 13.80 | -2.75% |
| 2004 | 14.19 | -96.07% |
| 2003 | 361.18 | 11,339.14% |
| 2002 | 3.16 | 0.00% |
P/E-ratio voor vergelijkbare bedrijven of concurrenten
| Bedrijf | P/E-ratio | Verschil in P/E-ratio | Land |
|---|---|---|---|
| -89.51 | -633.16% |
US
|
|
| 36.04 | 114.65% |
US
|
|
| 32.43 | 93.17% |
US
|
|
| - | - |
NL
|
|
| 69.16 | 311.97% |
US
|
Hoe lees je een P/E-ratio?
De koers-winstverhouding (P/E Ratio) meet de relatie tussen de aandelenprijs van een bedrijf en de winst per aandeel.
Een lage maar positieve P/E duidt op een bedrijf dat hoge winsten genereert ten opzichte van zijn huidige waardering en mogelijk ondergewaardeerd is. Een bedrijf met een hoge negatieve (dicht bij 0) P/E lijdt grote verliezen.
Bedrijven met een P/E boven 30 of een negatieve waarde worden meestal gezien als "groeiaandelen", wat betekent dat beleggers verwachten dat het bedrijf zal groeien of winstgevend zal worden.
Bedrijven met een positieve P/E onder de 10 worden meestal gezien als "waardeaandelen", wat betekent dat ze al zeer winstgevend zijn, maar weinig groei wordt verwacht.